3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)tetrahydrothiophene 1,1-dioxide

Catalog No. :
ACDQLY864
CAS No. :
1242282-03-6
Molecular Formula :
C11H17N3O2S
Molecular Weight :
255.34

IUPAC Name:3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)tetrahydrothiophene 1,1-dioxide

3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)tetrahydrothiophene 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)tetrahydrothiophene 1,1-dioxide
IUPAC Name3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)tetrahydrothiophene 1,1-dioxide
Molecular FormulaC11H17N3O2S
Molecular Weight255.34
SMILESNC1=C2CCCCC2=NN1C1CCS(=O)(=O)C1
InChI KeyKBFLNPWQFJBKNI-UHFFFAOYSA-N
Synonym2-(1,1-Dioxo-tetrahydro-1l6-thiophen-3-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ylamine;2H-Indazol-3-amine, 4,5,6,7-tetrahydro-2-(tetrahydro-1,1-dioxido-3-thienyl)-;3-(3-Amino-4,5,6,7-tetrahydro-2h-indazol-2-yl)tetrahydrothiophene 1,1-dioxide;3-(3-amino-4,5,6,7-tetrahydro-2H-indazol-2-yl)-1λ?-thiolane-1,1-dione
CAS No.1242282-03-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDQLY864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPNKV078 route compound structure diagram
    ACPNKV0781376043-30-9 In Stock
  4. Then
  5. ACDQLY864 route product structure diagram
    ACDQLY8641242282-03-6
Inquiry

2. ACDQLY864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDQLY864 route product structure diagram
    ACDQLY8641242282-03-6
Inquiry

Comments (0)